Using ‘Surfaceomics’ as a Jumping Point, a Case is Made for Clinical Lab Growth
Arun Wiita from USCF details his lab’s work using mass spectrometry
Arun Wiita from USCF details his lab’s work using mass spectrometry
From – Diagnostic Testing & Emerging Technologies
Physicians often fail to recommend genetic testing for breast cancer patients at high risk for mutations, according to a research letter published Feb…
From – Diagnostic Testing & Emerging Technologies
The case has been made repeatedly over the past few years regarding the need to increase physicians’ genomics knowledge. Now, for the first time…
From – Diagnostic Testing & Emerging Technologies
The application of pharmacogenomics (PGx) into routine, clinical care remains very limited, despite its potential to improve drug and…
From – Diagnostic Testing & Emerging Technologies
Nonsevere fetal malformations and structural abnormalities are relatively frequent findings of routine, prenatal ultrasounds. Yet, these findings provide…
From – Diagnostic Testing & Emerging Technologies
Despite the commonly held belief that the food allergy prevalence is rising, food allergies remain poorly studied and…
From – Diagnostic Testing & Emerging Technologies
Child–parent hypercholesterolemia (FH) screening is a practical and effective way of conducting population-based screening to identify the…
From – Diagnostic Testing & Emerging Technologies
With Theranos’ recent announcement of its transition away from laboratory operations toward technology development…